BFS
Beacon Financial Strategies Portfolio holdings
AUM
$179M
1-Year Est. Return
13.48%
This Fund
S&P 500
1 Year Est. Return
+13.48%
AUM
$179M
AUM Growth
+$9.67M
(+5.7%)
Holding
183
Top Buys
| 1 | +$296K | |
| 2 | +$283K | |
| 3 | +$197K | |
| 4 |
Humana
HUM
|
+$193K |
| 5 |
AbbVie
ABBV
|
+$180K |
Top Sells
| 1 | +$51.4K | |
| 2 | +$20.6K | |
| 3 | +$16.4K | |
| 4 |
Vanguard Growth ETF
VUG
|
+$16.1K |
| 5 |
GSK
GSK
|
+$15.7K |
Sector Composition
| 1 | Technology | 1.89% |
| 2 | Healthcare | 1.85% |
| 3 | Consumer Discretionary | 1.38% |
| 4 | Consumer Staples | 0.67% |
| 5 | Financials | 0.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
TripAdvisor
TRIP
$1.14B
| $1K | ﹤0.01% |
+69
|
|
||
177
Omnicom Group
OMC
$26.2B
| $889 | ﹤0.01% |
+11
|
|
||
178
Humacyte
HUMA
$214M
| $817 | ﹤0.01% |
+850
|
|
||
179
Charles River Laboratories
CRL
$8.63B
| $798 | ﹤0.01% |
+4
|
|
||
180
Precision BioSciences
DTIL
$99.7M
| $716 | ﹤0.01% |
+172
|
|
||
181
Boeing
BA
$180B
| $652 | ﹤0.01% |
+3
|
|
||
182
Angi Inc
ANGI
$308M
| $466 | ﹤0.01% |
+36
|
|
||
183
Vanguard Total Bond Market
BND
$151B
| – | – |
0
|
|